U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Distribuidora La Jugosita, Inc. - 532714 - 04/30/2021
  1. Warning Letters

CLOSEOUT LETTER

Distribuidora La Jugosita, Inc. MARCS-CMS 532714 —

Delivery Method:
VIA Electronic Mail
Reference #:
17-OHAFOE4-WL-07
Product:
Food & Beverages
Recipient:
Recipient Name
Mr. William Rodriquez
Recipient Title
President
Distribuidora La Jugosita, Inc.

Carretera #1, Km. 50.9
Cidra, PR 00739
United States

info@lajugosita.com
Issuing Office:
San Juan District Office

United States

(787) 729-8500

Dear Mr. Rodriguez:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 17-OHAFOE4-WL-07 dated August 17, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Kind regards,
/S/
Marilyn Santiago
Acting Director, Compliance Branch
Office of Human and Animal Food Operations
Division IV East

Back to Top